[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530818":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":33,"responsibleParty":63,"collaborators":65,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":19,"enrollmentInfo":77,"targetDuration":19,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":36,"whyStopped":19,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Centre Hospitalier Régional Metz-Thionville","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"excretion kinetics of gadolinium contrast agents in patients","EXPERIMENTAL","urine samples are collected before Gd-CAs injection, and between 0- and two-and-a-half-hour post-injection of Gd-CAs.",[13],"Other: biological samples collection",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"biological samples collection","Urine samples are collected before Gd-CAs injection, and between 0- and two-and-a-half-hour post-injection of Gd-CAs.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Rémi DUPRES, MD","CHR Metz Thionville Hopital Mercy","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":19,"email":30},"Arpiné EL NAR, PhD","CONTACT","0033387557766","projet-recherche-clinique@chr-metz-thionville.fr",{"name":32,"role":28,"phone":19,"phoneExt":19,"email":30},"Mélanie JUNKE",[34,50],{"facility":35,"status":36,"city":37,"state":38,"zip":19,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"CHR Metz-Thionville\u002FHopital de Mercy","RECRUITING","Metz","Grand Est","France","FR",{"type":42,"coordinates":43},"Point",[44,45],6.17269,49.11911,{"lat":45,"lon":44},[48,49],{"name":27,"role":28,"phone":29,"phoneExt":19,"email":30},{"name":22,"role":24,"phone":19,"phoneExt":19,"email":19},{"facility":51,"status":52,"city":53,"state":19,"zip":19,"country":39,"countryCode":40,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"CHR Metz-Thionville \u002F Hopital Bel Air","NOT_YET_RECRUITING","Thionville",{"type":42,"coordinates":55},[56,57],6.16044,49.35994,{"lat":57,"lon":56},[60,61],{"name":32,"role":28,"phone":19,"phoneExt":19,"email":30},{"name":62,"role":24,"phone":19,"phoneExt":19,"email":19},"Elisabeth PARIZEL, MD",{"type":64,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[66],{"name":67,"class":6},"University of Lorraine","100530818","kinetics-of-urinary-excretion-of-gadolinium-contrast-agents-used-in-mri-examinations-100530818",false,"NCT06191731","Kinetics of Urinary Excretion of Gadolinium Contrast Agents Used in MRI Examinations","GADODURABLE","Inclusion Criteria:\n\nPatients:\n\n* over 18 years of age\n* with a prescription for MRI with gadolinium-based contrast agents (Gd-CAs) injection validated by a radiologist\n* affiliated with a health insurance plan\n* have signed an informed consent form\n\nExclusion Criteria:\n\n* Patients:\n* with known allergy to gadolinium-based contrast agents (Gd-CAs)\n* with known severe renal impairment (GFR \\\u003C 30 mL\u002Fmin)\n* on dialysis\n* with urinary incontinence\n* with an ongoing urinary tract infection\n* under hydric or hydrosodic restriction\n* unable to urinate independently\n* Protected persons (under guardianship, curatorship or safeguard of justice)\n* Pregnant or breast-feeding women","ALL","18 Years",{"count":78,"type":79},60,"ESTIMATED","INTERVENTIONAL",[82],"NA","This is a single-center cohort study aimed to describe the urinary excretion kinetics of gadolinium contrast agents (Gd-CAs). Patients with a prescription for injected MRI are invited to participate in the study. If they agree, blood and urine samples are collected before Gd-CAs injection, and urine samples are collected between 0- and two-and-a-half-hours post-injection of Gd-CAs.",[85],"Magnetic Resonance Imaging",[87,88,89,90,91],"Contrast agents","Gadolinium","Recycling","MRI","Gadoteric acid","2026-06-20",{"date":94,"type":95},"2026-06-24","ACTUAL",{"date":97,"type":95},"2024-04-12",{"date":99,"type":79},"2028-04-12",{"name":5,"class":6},2]